Urol. praxi, 2012; 13(4): 173-175
Radical prostatectomy in patients with preoperative PSA above 20 ng/ml
- Urologická klinika FN a LF UK Hradec Králové
Radical prostatectomy for patients with PSA > 20 ng/ml preoperatively is linked to worse results including higher carcinoma-specific
mortality. Published data from retrospective studies prove high efficiency of the radical prostatectomy in selective cohort of patients.
There was evaluated cohort of 22 patients and median follow-up was 62 months. Median PSA was 28 ng/ml. All patients underwent
radical prostatectomy, 5 patients experienced of adjuvant radiotherapy and 4 of salvage radiotherapy. No patients died and no distant
metastases were recorded.
Keywords: high-risk prostate cancer, radical prostatectomy
Published: August 1, 2012 Show citation
References
- Albertsen PC, Hanley JA, Penson DF, Barrows G, Fine J. 13-year outcomes following treatment for clinically localized prostate cancer in a population based cohort J Urol. 2007; 177: 932-936.
Go to original source... 
Go to PubMed... - Merglen A, Schmidlin F, Fioretta G, Verkooijen HM, Rapiti E, Zanetti R, Miralbell R, Bouchardy C. Short- and long-term mortality with localized prostate cancer. Arch Intern Med. 2007; 167: 1944-1950. Go to original source... Go to PubMed...
- Stephenson AJ, Kattan MW, Eastham JA, et al. Prostate cancer specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. J ClinOncol 2009; 27: 4300-4305. Go to original source... Go to PubMed...
- Yossepowitch O, Eggener SE, Bianco Jr FJ, et al. Radical Prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods. J Urol 2007; 178: 493-499. Go to original source... Go to PubMed...
- Yossepowitch O, Eastham JA. Radical prostatectomy for high-risk prostate cancer. J Urol. 2008; 26: 219-224. Go to original source... Go to PubMed...
- Spahn M, Joniau S, Gontero P, Fieuws S, Marchioro G, Tombal B, Kneitz B, Hsu CY, Van Der Eeckt K, Bader P, Frohneberg D, Tizzani A, Van Poppel H. Outcome predictors of radical prostatectomy in patients with prostate-specific antigen greater than 20 ng/ml: a European multi-institutional study of 712 patients.Eur Urol. 2010; 58: 1-7. Go to original source... Go to PubMed...
- Ploussard G, Masson-Lecomte A, Beauval JB, Ouzzane A, Bonniol R, Buge F, Fadli S, Roupr?t M, Rebillard X, Gaschignard N, Pfister C, Villers A, Soulié M, Salomon L. Radical prostatectomy for high-risk prostate cancer defined by preoperative criteria: Oncologic follow-up in National Multicenter Study in 813 patients and assessment of easy-to-use prognostic substratification. Urology. 2011 Jul 21 doi: 10.1016/j.physletb.2003.10.071. Go to original source... Go to PubMed...
- Connolly SS, Oon SF, Carroll C, Kinsella S, O'Brien MF, Mulvin DW, Quinlan DM. Radical prostatectomy outcome when performed with PSA above 20 ng/ml. Ir Med J. 2011; 104: 108-111. Go to PubMed...
- Gontero P, Spahn M, Tombal B, Bader P, Hsu CY, Marchioro G, Frea B, Van Der Eeckt K, Kneitz B, Frohneberg D, Tizzani A, Van Poppel H, Joniau S. Ist here a prostate-specific antigen upper limit for radical prostatectomy? BJU Int. 2011 Mar 10. doi: 10.1111/j.1464-410X.2011.10076.x. Go to original source... Go to PubMed...
- Meng MV, Elkin EP, Latini DM, Duchane J, Carroll PR. Treatment of patients with high risk localized prostate cancer: results from cancer of the prostate strategic urological research endeavor (CaPSURE). J Urol 2005; 173: 1557-152461. Go to original source... Go to PubMed...
- Vargas C, Martínez A, Galalae R, Demanes J, Harsolia A, Schour L, Nuernberg N, Gonzalez J. High-dose radiation employing external beam radiotherapy and high-dose rate brachytherapy with and without neoadjuvant androgen deprivation for prostate cancer patients with intermediate- and high-risk features. Prostate Cancer Prostatic Dis. 2006; 9: 245-255. Go to original source... Go to PubMed...
- Amling CL, Bergstralh EJ, Blute ML, Slezak JM, Zincke H. Defining prostate specific antigen progression after radical prostatectomy: Chat is the most appropriate cut point? J Urol 2001; 165: 1146-1151. Go to original source... Go to PubMed...
- Takaha N, Okihara K, Kamoi K, Kimura Y, Yamada T, Kawauchi A, Kobayashi K, Yamazaki H, Nishimura T, Miki T. Optimal duration of androgen deprivation in combination with radiation therapy for Japanese men with high-risk prostate cancer. Urol Int. 2011; 87: 28-34. Go to original source... Go to PubMed...
- Fang LC, Merrick GS, WallnerKE. Androgen deprivation therapy: a survival benefit or detriment in men with highrisk prostate cancer? Oncology (Williston Park). 2010; 24: 790-796. Go to PubMed...
- Boorjian SA, Karnes RJ, Viterbo R, Rangel LJ, Bergstralh EJ, Horwitz EM, Blute ML, Buyyounouski MK. Long-term surfoval after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer. Cancer. 2011; 117: 2883-2891. Go to original source... Go to PubMed...